The New Gold Standard for Obesity: Semaglutide & Tirzepatide Injections (GLP-1)

Health Dimensions Clinical Pharmacy (HDRx) is a PCAB-accredited sterile compounding pharmacy, specializing in compounded injection medications, including GLP-1 medications, Semaglutide and Tirzepatide. Shipping to multiple states with prescription (MI, OH, IN, IL, IN, WI, and MN).

PCAB Logo - HDRX is an Accredited Compounding Pharmacy

Michigan has one of the highest obesity rates in the United States, consistently ranking in the top 10 to 15 most obese states.


In Michigan, as in many parts of the United States, obesity remains a critical public health challenge. 

In 2022, the CDC’s Behavioral Risk Factor Surveillance System (BRFSS) reported that 34.5% of Michigan adults had a body mass index (BMI) of 30 or higher, which is considered obese. This is higher than the national average of 33.6%.

Source: America’s Health Rankings

This significant portion of the population is at an increased risk for a host of serious health issues, including type 2 diabetes, heart disease, and other conditions. To combat the growing number of people with obesity, Semaglutide and Tirzepatide injections have emerged as pivotal tools in the battle against obesity (and related conditions), offering new hope and improved outcomes for those struggling with weight management.

Being overweight or obese may lead to a number of health conditions, such as:

  • Sleep apnea
  • • Type 2 diabetes
  • • High blood pressure
  • • Heart disease
  • • Stroke
  • • Metabolic syndrome
  • • Fatty liver diseases
  • • Some cancers
  • • Breathing problems
  • • Osteoarthritis
  • • Gout
  • • Diseases of the gallbladder
  • • Pancreatic disease
  • • Kidney disease
  • • Pregnancy problems
  • • Fertility problems
  • • Sexual function problems
  • More


Source: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Medical practitioners with patients that are suffering from the conditions listed, may find success by addressing underlying obesity at the core, with Semaglutide or Tirzepatide.

Understanding Semaglutide and Tirzepatide

Semaglutide and Tirzepatide belong to a class of medications known as GLP-1 receptor agonists. These drugs work by mimicking the effects of the naturally occurring hormone GLP-1 (glucagon-like peptide-1) receptor agonists, which is critical in regulating blood sugar and satiety (feeling full). By enhancing the body’s natural responses, these medications help to reduce appetite (by increasing feeling of fullness) and improve blood sugar levels, which are vital steps in managing obesity and type 2 diabetes.


Semaglutide = active ingredient in Ozempic & Wegovy

Tirzepatide = active ingredient in Mounjaro & Zepbound


Commercially available Ozempic, Wegovy, Mounjaro, and Zepbound are in shortage, and Health Dimensions Clinical Pharmacy (HDRx) has helped patients in multiple states to get the medication they need. These medications have been going viral in the media as celebrities and influencers share their success stories. People who have been struggling with being overweight, now have an opportunity and hope for significant weight loss without surgery.

HDRx offers compounded Semaglutide & Tirzepatide to patients in multiple states.

Prescription required. HDRx is licensed to ship prescriptions to MI, OH, IN, IL, IN, WI, and MN.

Semaglutide: A Versatile Tool in Weight Management

  Initially approved for the treatment of type 2 diabetes, Semaglutide has gained widespread recognition for patients’ significant weight loss results. Clinical trials have shown that it can lead to significant weight reduction in individuals with obesity, often surpassing what has been achieved through lifestyle changes or bariatric surgery. This has made it an invaluable option for those whose weight poses a health risk or hinders their quality of life.

HDRx offers compounded Semaglutide to patients:


Tirzepatide: The Next Step in Obesity Management

Following in the footsteps of Semaglutide, Tirzepatide combines the actions of GLP-1 with GIP (glucose-dependent insulinotropic polypeptide) to further enhance weight loss efforts. Studies and clinical trials indicate that Tirzepatide may even surpass Semaglutide in its ability to reduce body weight, offering an exciting new avenue for those who have struggled with other methods of weight loss.

Where to Get GLP-1 Weight Loss Medications (Semaglutide & Tirzepatide Injections): Health Dimensions Clinical Pharmacy (HDRx)

At HDRx, we understand the challenges faced by those dealing with obesity and its related conditions. As a leading compounding pharmacy in Michigan (also serving multiple states), HDRx offers both Semaglutide and Tirzepatide injections as prescribed by licensed practitioners.

Who is Health Dimensions (HDRx) and how do they get Semaglutide? 

Health Dimensions (HDRx) is a nationally accredited compounding pharmacy. We are one of the nation’s first accredited compounding pharmacies. Materials that are legally authorized for compounding are defined in the Food, Drug, and Cosmetic Act. 

Therefore, a compounding pharmacy (503A and 503B) must meet certain requirements established by the FDA and the Board of Pharmacy to prepare Semaglutide. HDRx sources Semaglutide from an FDA registered supplier. Our facility and quality management system are accredited by the Accreditation System for Healthcare for compliance with the United States Pharmacopeia, the scientific body that creates standards for both drug manufacturing and pharmacy compounding. HDRx compounded Semaglutide meets the regulatory requirements for compounding. 

Ready to Prescribe GLP-1 Medications for Your Patients?

Tackle Obesity & Obesity-Related Disease with GLP-1 Medications


As obesity continues to be a major health issue, the importance of advancements in new options for weight loss cannot be overstated. Semaglutide and Tirzepatide injections represent the forefront of obesity management, providing powerful tools for patients and healthcare providers alike. With ongoing research and positive patient outcomes, these medications stand as a testament to the advancements in medical science aimed at improving lives.

If you are struggling with obesity, contact our pharmacy or ask your doctor whether Semaglutide or Tirzepatide could be part of your health journey. Doctors, reach out to our team to offer the most comprehensive guidance from the initial prescribing process to proper dosing escalation. We’ll be there for you or your patients from start to finish, and look forward to playing our part in their weight-loss journeys.


Cawley, J., Biener, A., Meyerhoefer, C., Ding, Y., Zvenyach, T., Smolarz, B. G., & Ramasamy, A. (2021). Direct medical costs of obesity in the United States and the most populous states. Journal of managed care & specialty pharmacy, 27(3), 354-366.

Gallwitz, B. (2022). Clinical perspectives on the use of the GIP/GLP-1 receptor agonist tirzepatide for the treatment of type-2 diabetes and obesity. Frontiers in Endocrinology, 13, 1004044.

le Roux, C. W., Hankosky, E. R., Wang, D., Malik, R., Yu, M., Hickey, A., … & Wharton, S. (2023). Tirzepatide 10 and 15 mg compared with semaglutide 2.4 mg for the treatment of obesity: an indirect treatment comparison. Diabetes, Obesity and Metabolism, 25(9), 2626-2633.

Tiwari A, Balasundaram P. Public Health Considerations Regarding Obesity. [Updated 2023 Jun 5]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing

MPA logo - health dimensions clinical pharmacy is michigan pharmacists association member
PCAB Logo - HDRX is an Accredited Compounding Pharmacy
HDRX is an Alliance for Pharmacy Compounding member - logo
PCCA - Health Dimensions Clinical Pharmacy is a PCCA member
Health Dimensions is an APMS member
Pharmacy Compounding Accreditation Board - Logo
podiatry and compounding

How Podiatrists Work with Compounding Pharmacists

Regardless of the medications involved, the close partnership between a podiatrist and a compounding pharmacy provides ...

This is a Text Box


This is a CTA

Test box with CTA


This is a blurb

This is text on a blurb

Skip to content